Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.
about
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsEnzymatically active biomimetic micropropellers for the penetration of mucin gels.Candida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic proteaseNanodelivery in airway diseases: challenges and therapeutic applications.Aspergillosis and the role of mucins in cystic fibrosisExtracellular enolase of Candida albicans is involved in colonization of mammalian intestinal epitheliumIn vivo analysis of secreted aspartyl proteinase expression in human oral candidiasisNon-serum-dependent chemotactic factors produced by Candida albicans stimulate chemotaxis by binding to the formyl peptide receptor on neutrophils and to an unknown receptor on macrophagesCharacterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli.Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells.Cell wall and secreted proteins of Candida albicans: identification, function, and expressionWild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitroTranscriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infectionInfluence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress.Candida albicans secreted aspartyl proteinases in virulence and pathogenesisDisruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasisGenetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c miceCooperative Evolutionary Strategy between the Bacteriome and Mycobiome.Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.Proteolytic activation of the interleukin-1beta precursor by Candida albicans.Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p.Tetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening.The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils.Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.In Vitro Characterization of Lactobacillus plantarum Strains with Inhibitory Activity on Enteropathogens for Use as Potential Animal Probiotics.Candida-Epithelial Interactions.
P2860
Q27325713-AEF700B6-1FC1-4FA1-9E5E-ACE1AFD1F15AQ27339714-CF29A0E4-820C-4330-851C-B77822EAB205Q28481265-1AF8C40F-6047-42D4-A45A-7D6DF539AFFEQ33483926-0410EEA8-2B01-4FAE-8230-8753266D206FQ33578465-FF894DAF-E176-46C2-AA39-C46A10B2EDC5Q33701788-7019C0D3-D633-452E-A75E-08E1784B52A0Q33867435-85DE2E8F-D084-40D6-B107-3223D315F8E4Q34000516-32467EC1-64F7-4E50-9EFB-180F6BD6BB92Q34002298-03C37A5C-4F81-4FB5-8898-E95FB4457CDDQ34004578-DF4EA7C2-E7D5-4528-95E4-E11F2132E32CQ34009982-7D7E539B-B99D-459E-9854-65F4667E922AQ34081541-D1869918-B81D-4432-A2E7-C6554D72A3DFQ34112321-4DC79AD3-7DBB-4939-967B-80EA20478476Q34117682-F4A11463-2F10-4B1B-909A-B63F3DF92197Q35091118-497C2A69-B0A8-45F5-9F39-D9B77744701EQ35215948-D6DECC70-3B08-4672-9744-8FC9D435594FQ35554184-20A1C42E-7BF1-4BD0-A215-DB3E27F50310Q35562549-5332D9F8-B7C0-4F77-9705-2E9DE289914DQ35920633-5C5667AE-3A1F-4F6A-A0F3-643A27458E48Q35923224-A5554872-192D-4C9E-B9A3-AD0E804DE693Q36788780-B82DC02B-572C-41F9-B1B8-5C8C6AA8E7AFQ36977827-995F7F9D-618D-43D2-9219-E259B62DDE68Q37417375-CF06CF79-D5A1-457C-887F-082248ACD52FQ39471544-056853AB-A903-493F-8C02-813E621B8675Q39569992-D6381B8B-E98E-44F1-8183-99103F30BA79Q40163058-D954F2D5-E8BA-4772-A2EF-7495E6EDC688Q41768949-A77231C3-D7C4-44DB-83A9-34801375BE8CQ42688094-A8F8A18C-D3FA-421F-8BFD-16BB1CA09434Q44792128-70E27423-7C4D-4390-8978-EB0D4BD60FB1Q48021396-9A501129-DDD2-4E18-BF95-3E338B0542B5Q50117670-E6AB6A47-F6C4-493F-972B-3812E2C9E8DA
P2860
Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@en
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@nl
type
label
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@en
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@nl
prefLabel
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@en
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@nl
P2093
P2860
P1476
Evidence for degradation of ga ...... secretory aspartyl proteinase.
@en
P2093
Belhumeur P
Deslauriers N
de Repentigny L
P2860
P304
P407
P577
1996-11-01T00:00:00Z